Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score
<p><strong>Objective</strong> To develop and validate a pragmatic risk score to predict mortality in patients admitted to hospital with coronavirus disease 2019 (covid-19).</p> <p><strong>Design</strong> Prospective observational cohort study.</p> &l...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Journal article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020
|
| _version_ | 1797086426650640384 |
|---|---|
| author | Knight, SR Ho, A Pius, R Buchan, I Carson, G Drake, TM Dunning, J Fairfield, CJ Gamble, C Green, CA Gupta, R Halpin, S Hardwick, HE Holden, KA Horby, PW Jackson, C Mclean, KA Merson, L Nguyen-Van-Tam, JS Norman, L Noursadeghi, M Olliaro, PL Pritchard, MG Russell, CD Shaw, CA Sheikh, A Solomon, T Sudlow, C Swann, OV Turtle, LCW Openshaw, PJM Baillie, JK Semple, MG Docherty, AB Harrison, EM |
| author2 | Sigfrid, L |
| author_facet | Sigfrid, L Knight, SR Ho, A Pius, R Buchan, I Carson, G Drake, TM Dunning, J Fairfield, CJ Gamble, C Green, CA Gupta, R Halpin, S Hardwick, HE Holden, KA Horby, PW Jackson, C Mclean, KA Merson, L Nguyen-Van-Tam, JS Norman, L Noursadeghi, M Olliaro, PL Pritchard, MG Russell, CD Shaw, CA Sheikh, A Solomon, T Sudlow, C Swann, OV Turtle, LCW Openshaw, PJM Baillie, JK Semple, MG Docherty, AB Harrison, EM |
| author_sort | Knight, SR |
| collection | OXFORD |
| description | <p><strong>Objective</strong> To develop and validate a pragmatic risk score to predict mortality in patients admitted to hospital with coronavirus disease 2019 (covid-19).</p>
<p><strong>Design</strong> Prospective observational cohort study.</p>
<p><strong>Setting</strong> International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) World Health Organization (WHO) Clinical Characterisation Protocol UK (CCP-UK) study (performed by the ISARIC Coronavirus Clinical Characterisation Consortium—ISARIC-4C) in 260 hospitals across England, Scotland, and Wales. Model training was performed on a cohort of patients recruited between 6 February and 20 May 2020, with validation conducted on a second cohort of patients recruited after model development between 21 May and 29 June 2020.</p>
<p><strong>Participants</strong> Adults (age ≥18 years) admitted to hospital with covid-19 at least four weeks before final data extraction.</p>
<p><strong>Main outcome measure</strong> In-hospital mortality.</p>
<p><strong>Results</strong> 35 463 patients were included in the derivation dataset (mortality rate 32.2%) and 22 361 in the validation dataset (mortality rate 30.1%). The final 4C Mortality Score included eight variables readily available at initial hospital assessment: age, sex, number of comorbidities, respiratory rate, peripheral oxygen saturation, level of consciousness, urea level, and C reactive protein (score range 0-21 points). The 4C Score showed high discrimination for mortality (derivation cohort: area under the receiver operating characteristic curve 0.79, 95% confidence interval 0.78 to 0.79; validation cohort: 0.77, 0.76 to 0.77) with excellent calibration (validation: calibration-in-the-large=0, slope=1.0). Patients with a score of at least 15 (n=4158, 19%) had a 62% mortality (positive predictive value 62%) compared with 1% mortality for those with a score of 3 or less (n=1650, 7%; negative predictive value 99%). Discriminatory performance was higher than 15 pre-existing risk stratification scores (area under the receiver operating characteristic curve range 0.61-0.76), with scores developed in other covid-19 cohorts often performing poorly (range 0.63-0.73).</p>
<p><strong>Conclusions</strong> An easy-to-use risk stratification score has been developed and validated based on commonly available parameters at hospital presentation. The 4C Mortality Score outperformed existing scores, showed utility to directly inform clinical decision making, and can be used to stratify patients admitted to hospital with covid-19 into different management groups. The score should be further validated to determine its applicability in other populations.</p>
<p><strong>Study registration</strong> ISRCTN66726260</p> |
| first_indexed | 2024-03-07T02:21:54Z |
| format | Journal article |
| id | oxford-uuid:a4398131-6141-41ba-8c6e-7072edf4aad8 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T02:21:54Z |
| publishDate | 2020 |
| publisher | BMJ Publishing Group |
| record_format | dspace |
| spelling | oxford-uuid:a4398131-6141-41ba-8c6e-7072edf4aad82022-03-27T02:32:25ZRisk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality ScoreJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a4398131-6141-41ba-8c6e-7072edf4aad8EnglishSymplectic ElementsBMJ Publishing Group2020Knight, SRHo, APius, RBuchan, ICarson, GDrake, TMDunning, JFairfield, CJGamble, CGreen, CAGupta, RHalpin, SHardwick, HEHolden, KAHorby, PWJackson, CMclean, KAMerson, LNguyen-Van-Tam, JSNorman, LNoursadeghi, MOlliaro, PLPritchard, MGRussell, CDShaw, CASheikh, ASolomon, TSudlow, CSwann, OVTurtle, LCWOpenshaw, PJMBaillie, JKSemple, MGDocherty, ABHarrison, EMSigfrid, L<p><strong>Objective</strong> To develop and validate a pragmatic risk score to predict mortality in patients admitted to hospital with coronavirus disease 2019 (covid-19).</p> <p><strong>Design</strong> Prospective observational cohort study.</p> <p><strong>Setting</strong> International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) World Health Organization (WHO) Clinical Characterisation Protocol UK (CCP-UK) study (performed by the ISARIC Coronavirus Clinical Characterisation Consortium—ISARIC-4C) in 260 hospitals across England, Scotland, and Wales. Model training was performed on a cohort of patients recruited between 6 February and 20 May 2020, with validation conducted on a second cohort of patients recruited after model development between 21 May and 29 June 2020.</p> <p><strong>Participants</strong> Adults (age ≥18 years) admitted to hospital with covid-19 at least four weeks before final data extraction.</p> <p><strong>Main outcome measure</strong> In-hospital mortality.</p> <p><strong>Results</strong> 35 463 patients were included in the derivation dataset (mortality rate 32.2%) and 22 361 in the validation dataset (mortality rate 30.1%). The final 4C Mortality Score included eight variables readily available at initial hospital assessment: age, sex, number of comorbidities, respiratory rate, peripheral oxygen saturation, level of consciousness, urea level, and C reactive protein (score range 0-21 points). The 4C Score showed high discrimination for mortality (derivation cohort: area under the receiver operating characteristic curve 0.79, 95% confidence interval 0.78 to 0.79; validation cohort: 0.77, 0.76 to 0.77) with excellent calibration (validation: calibration-in-the-large=0, slope=1.0). Patients with a score of at least 15 (n=4158, 19%) had a 62% mortality (positive predictive value 62%) compared with 1% mortality for those with a score of 3 or less (n=1650, 7%; negative predictive value 99%). Discriminatory performance was higher than 15 pre-existing risk stratification scores (area under the receiver operating characteristic curve range 0.61-0.76), with scores developed in other covid-19 cohorts often performing poorly (range 0.63-0.73).</p> <p><strong>Conclusions</strong> An easy-to-use risk stratification score has been developed and validated based on commonly available parameters at hospital presentation. The 4C Mortality Score outperformed existing scores, showed utility to directly inform clinical decision making, and can be used to stratify patients admitted to hospital with covid-19 into different management groups. The score should be further validated to determine its applicability in other populations.</p> <p><strong>Study registration</strong> ISRCTN66726260</p> |
| spellingShingle | Knight, SR Ho, A Pius, R Buchan, I Carson, G Drake, TM Dunning, J Fairfield, CJ Gamble, C Green, CA Gupta, R Halpin, S Hardwick, HE Holden, KA Horby, PW Jackson, C Mclean, KA Merson, L Nguyen-Van-Tam, JS Norman, L Noursadeghi, M Olliaro, PL Pritchard, MG Russell, CD Shaw, CA Sheikh, A Solomon, T Sudlow, C Swann, OV Turtle, LCW Openshaw, PJM Baillie, JK Semple, MG Docherty, AB Harrison, EM Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score |
| title | Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score |
| title_full | Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score |
| title_fullStr | Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score |
| title_full_unstemmed | Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score |
| title_short | Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score |
| title_sort | risk stratification of patients admitted to hospital with covid 19 using the isaric who clinical characterisation protocol development and validation of the 4c mortality score |
| work_keys_str_mv | AT knightsr riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT hoa riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT piusr riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT buchani riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT carsong riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT draketm riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT dunningj riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT fairfieldcj riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT gamblec riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT greenca riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT guptar riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT halpins riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT hardwickhe riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT holdenka riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT horbypw riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT jacksonc riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT mcleanka riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT mersonl riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT nguyenvantamjs riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT normanl riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT noursadeghim riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT olliaropl riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT pritchardmg riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT russellcd riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT shawca riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT sheikha riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT solomont riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT sudlowc riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT swannov riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT turtlelcw riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT openshawpjm riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT bailliejk riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT semplemg riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT dochertyab riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore AT harrisonem riskstratificationofpatientsadmittedtohospitalwithcovid19usingtheisaricwhoclinicalcharacterisationprotocoldevelopmentandvalidationofthe4cmortalityscore |